[Bio NEWS] The First week of March. 120 million do..

[Bio NEWS] The Fourth week of February. Digital th..

[Bio NEWS] The Third week of February. K-bio aims ..

[Bio NEWS] The Second week of February. Korea to i..

[Full ver.] SPECIAL TALK with AblBio CEO Lee Sang ..

[Bio NEWS] The Fourth week of January. Korean Gove..

Global Leader of Cancer Stem Cell-Based Drug & Bus..

Cenyx Biotech, a biotech seeking to develop world'..

New pioneer in mRNA-based therapeutic field, De No..

The best than the first, BioApp & Dr. Sohn

The Future of Drug Delivery Platform, MDimune Inc.

The Autoimmune Specialists’ CRO with State-of-the-..

Official highlights of BIOPLUS-INTERPHEX KOREA 202

2021 BIO Digital 디브리핑 세미나

[바이오기업 역량강화 세미나] 해외진출 계약서 체결 등 법적 고려사항

[바이오기업 역량강화 세미나] 미국 임상 시험에 적합한 CRO 선택

[바이오기업 역량강화 세미나] 미국 내 의약품 출시: 신약 개발자를 위한 FDA 승인,..

[바이오기업 역량강화 세미나] [대담] 국내기업 해외진출 성공열쇠